Literature DB >> 2265776

Jejunal immunoglobulin and antigliadin antibody secretion in adult coeliac disease.

J F Colombel1, F Mascart-Lemone, J Nemeth, J P Vaerman, C Dive, J C Rambaud.   

Abstract

We compared the local intestinal immunoglobulin (Ig) secretion in six adult patients with coeliac disease and nine control subjects by perfusion of a small bowel segment under an occluding balloon and analysis of the perfusion fluid for the content of Ig and secretory component. The results were compared to the number of Ig-containing plasma cells in the test segment. There was, respectively, a two-fold and a fivefold increase in jejunal secretion rates of IgA (both monomeric and polymeric) and IgM in patients with coeliac disease compared with control subjects. The high IgA and IgM secretion rates parallel the increase of Ig-containing plasma cells in the lamina propria. In contrast, the IgG plasma cell density increase was barely significant in patients with coeliac disease and did not result in a high IgG secretion rate. The jejunal secretion rate of secretory component was significantly increased in patients with coeliac disease and no free dimeric IgA was present in the jejunal fluid. Antigliadin-IgA was detected in the serum and jejunal fluid of the six patients with coeliac disease. Antigliadin-IgA, however, was almost entirely polymeric IgA linked to secretory component in jejunal fluid, whereas 61% was dimeric IgA not linked to secretory component in serum. This result, combined with a raised secretory component secretion rate with no evidence of secretory component saturation, suggests that serum and intestinal antigliadin IgA might be of different origins in coeliac disease.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2265776      PMCID: PMC1378754          DOI: 10.1136/gut.31.12.1345

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  27 in total

1.  Immunoglobulin secretion by isolated intestinal lymphocytes: spontaneous production and T-cell regulation in normal small intestine and in patients with coeliac disease.

Authors:  J E Crabtree; R V Heatley; M L Losowsky
Journal:  Gut       Date:  1989-03       Impact factor: 23.059

Review 2.  Lymphoepithelial interactions in the mucosal immune system.

Authors:  P Brandtzaeg; L M Sollid; P S Thrane; D Kvale; K Bjerke; H Scott; K Kett; T O Rognum
Journal:  Gut       Date:  1988-08       Impact factor: 23.059

3.  Immunological study of histologically non-involved jejunum during Crohn's disease: evidence for reduced in vivo secretion of secretory IgA.

Authors:  P Marteau; J F Colombel; J Nemeth; J P Vaerman; J C Dive; J C Rambaud
Journal:  Clin Exp Immunol       Date:  1990-05       Impact factor: 4.330

4.  Mucosal secretory IgA and secretory piece in adult coeliac disease.

Authors:  R J Shiner; J Ballard
Journal:  Gut       Date:  1973-10       Impact factor: 23.059

5.  IgA antigliadin antibodies in celiac and inflammatory bowel disease.

Authors:  C R Koninckx; J P Giliams; I Polanco; A S Peña
Journal:  J Pediatr Gastroenterol Nutr       Date:  1984-11       Impact factor: 2.839

6.  Relation between HLA-DR-like antigens and secretory component (SC) in jejunal epithelium of patients with coeliac disease or dermatitis herpetiformis.

Authors:  H Scott; P Brandtzaeg; B G Solheim; E Thorsby
Journal:  Clin Exp Immunol       Date:  1981-05       Impact factor: 4.330

7.  Interferon-gamma enhances expression of secretory component, the epithelial receptor for polymeric immunoglobulins.

Authors:  L M Sollid; D Kvale; P Brandtzaeg; G Markussen; E Thorsby
Journal:  J Immunol       Date:  1987-06-15       Impact factor: 5.422

8.  Jejunal mucosal immunoglobulin-containing cells and jejunal fluid immunoglobulins in adult coeliac disease and dermatitis herpetiformis.

Authors:  M Lancaster-Smith; P Kumar; R Marks; M L Clark; A M Dawson
Journal:  Gut       Date:  1974-05       Impact factor: 23.059

9.  Jejunal plasma cells and in vitro immunoglobulin production in adult coeliac disease.

Authors:  G M Wood; P D Howdle; L K Trejdosiewicz; M S Losowsky
Journal:  Clin Exp Immunol       Date:  1987-07       Impact factor: 4.330

10.  IgA antigliadin antibodies: a marker of mucosal damage in childhood coeliac disease.

Authors:  E Savilahti; M Viander; M Perkkiö; E Vainio; K Kalimo; T Reunala
Journal:  Lancet       Date:  1983-02-12       Impact factor: 79.321

View more
  8 in total

1.  Effect of intrajejunal elemental diet perfusion on jejunal secretion of immunoglobulins, albumin, and hyaluronan in man.

Authors:  J F Colombel; J P Vaerman; R Hällgren; J P Dehennin; E Wain; R Modigliani; A Cortot
Journal:  Gut       Date:  1992-01       Impact factor: 23.059

2.  The changing face of celiac disease.

Authors:  R Lad; K Jacobson
Journal:  Paediatr Child Health       Date:  2001-11       Impact factor: 2.253

Review 3.  Immunopathology of gluten-sensitive enteropathy.

Authors:  H Scott; E Nilsen; L M Sollid; K E Lundin; J Rugtveit; O Molberg; E Thorsby; P Brandtzaeg
Journal:  Springer Semin Immunopathol       Date:  1997

4.  Evidence for differential effects of sulphasalazine on systemic and mucosal immunity in rheumatoid arthritis.

Authors:  L Kanerud; G N Engström; A Tarkowski
Journal:  Ann Rheum Dis       Date:  1995-04       Impact factor: 19.103

5.  Activated eosinophils in adult coeliac disease: evidence for a local release of major basic protein.

Authors:  J F Colombel; G Torpier; A Janin; O Klein; A Cortot; M Capron
Journal:  Gut       Date:  1992-09       Impact factor: 23.059

6.  Gut mucosal immunity to tissue transglutaminase in untreated celiac disease and other gastrointestinal disorders.

Authors:  Anna Dahele; Marian C Aldhous; Kathleen Kingstone; Kennneth Humphreys; John Bode; Margaret McIntyre; Subrata Ghosh
Journal:  Dig Dis Sci       Date:  2002-10       Impact factor: 3.199

7.  Modeling of celiac disease immune response and the therapeutic effect of potential drugs.

Authors:  Oleg O Demin; Sergey V Smirnov; Victor V Sokolov; Lourdes Cucurull-Sanchez; Cesar Pichardo-Almarza; M Victoria Flores; Neil Benson; Oleg V Demin
Journal:  BMC Syst Biol       Date:  2013-07-05

8.  Interleukin 5 messenger RNA expression by eosinophils in the intestinal mucosa of patients with coeliac disease.

Authors:  P Desreumaux; A Janin; J F Colombel; L Prin; J Plumas; D Emilie; G Torpier; A Capron; M Capron
Journal:  J Exp Med       Date:  1992-01-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.